Cases & Deals

Maverick Capital invests in Microbia

Clients Maverick Capital Ltd.

Jones Day counseled Maverick Capital Ltd. in connection with its purchase of $78.3 million of Series E Convertible Preferred Stock in a private placement by Microbia, Inc., a developer and marketer of pharmaceuticals for the healthcare industry.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.